Response to HER2 Inhibition in a Patient With Brain Metastasis With EGFR TKI Acquired Resistance and an HER2 Amplification

A 62-year-old man was referred to our university hospital for treatment of advanced adenocarcinoma of the lung after disease progression on two lines of EGFR TKI and one line of chemotherapy. Fluorescent in situ hybridization analysis upon progression showed an HER2 amplification. At our weekly Mole...

Descripción completa

Detalles Bibliográficos
Autores principales: Meedendorp, Arenda D., ter Elst, Arja, ’t Hart, Nils A., Groen, Harry J. M., Schuuring, Ed, van der Wekken, Anthonie J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972286/
https://www.ncbi.nlm.nih.gov/pubmed/29872644
http://dx.doi.org/10.3389/fonc.2018.00176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972286/
https://www.ncbi.nlm.nih.gov/pubmed/29872644
http://dx.doi.org/10.3389/fonc.2018.00176

Ejemplares similares